Axogen, Inc. Repayments of Long-Term Debt
Axogen, Inc. (AXGN) reported Repayments of Long-Term Debt of $48.59 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Cash Flow › Financing Activities
us-gaap:RepaymentsOfLongTermDebt · last filed 2026-07-29
- Axogen, Inc. repayments of long-term debt for the quarter ending 2026-06-30 was $0.00.
- Axogen, Inc. repayments of long-term debt for the quarter ending 2026-03-31 was $48.59M.
- Axogen, Inc. repayments of long-term debt for the quarter ending 2025-06-30 was $0.00.
- Axogen, Inc. repayments of long-term debt for the quarter ending 2025-03-31 was $0.00.
- Axogen, Inc. repayments of long-term debt for fiscal 2020 was $0.00.
- Axogen, Inc. repayments of long-term debt for fiscal 2019 was $0.00, a 100.00% decline from fiscal 2018.
- Axogen, Inc. repayments of long-term debt for fiscal 2018 was $22.51M, a 107104.76% increase from fiscal 2017.
- Axogen, Inc. repayments of long-term debt for fiscal 2017 was $21.00K, a 99.14% decline from fiscal 2016.
| Period end | Repayments of Long-term Debt | Repayments of Long-term Debt 3 month | Repayments of Long-term Debt 3 month as first filed | Repayments of Long-term Debt 6 month | Repayments of Long-term Debt 6 month as first filed | Repayments of Long-term Debt 9 month | Repayments of Long-term Debt 9 month as first filed | Repayments of Long-term Debt 12 month | Repayments of Long-term Debt 12 month as first filed |
|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $48.59M 10-Q · filed 2026-07-29 | |||||||
| 2026-03-31 | $48.59M 10-Q · filed 2026-04-28 | ||||||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-07-29 | $0.00 10-Q · filed 2026-07-29 | |||||||
| 2025-03-31 | $0.00 10-Q · filed 2026-04-28 | ||||||||
| 2020-12-31 | $0.00 10-K · filed 2021-03-01 | ||||||||
| 2019-12-31 | $0.00 10-K · filed 2021-03-01 | ||||||||
| 2018-12-31 | $10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $21.00K derived: sum of 2 quarters · filed 2021-03-01 | $22.51M derived: sum of 3 quarters · filed 2021-03-01 | $22.51M 10-K · filed 2021-03-01 | |||||
| 2018-09-30 | $11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $22.50M derived: sum of 2 quarters · filed 2019-11-06 | $22.50M 10-Q · filed 2019-11-06 | $22.50M 10-Q · filed 2018-10-29 | $22.51M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-06-30 | $22.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $22.49M 10-Q · filed 2019-08-06 | $22.49M 10-Q · filed 2018-08-01 | $22.50M derived: sum of 3 quarters · filed 2020-02-24 | $22.50M derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2018-05-22 | $22.60M 10-K · filed 2020-02-24 | ||||||||
| 2018-03-31 | $3.00K 10-Q · filed 2019-05-08 | $3.17K 10-Q · filed 2018-04-30 | $8.41K derived: sum of 2 quarters · filed 2020-02-24 | $15.43K derived: sum of 3 quarters · filed 2020-02-24 | $18.84K derived: sum of 4 quarters · filed 2020-02-24 | ||||
| 2017-12-31 | $5.41K derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-24 | $12.43K derived: sum of 2 quarters · filed 2020-02-24 | $15.84K derived: sum of 3 quarters · filed 2020-02-24 | $21.00K 10-K · filed 2020-02-24 | $20.90K 10-K · filed 2018-02-28 | ||||
| 2017-09-30 | $7.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-10-29 | $10.43K derived: sum of 2 quarters · filed 2018-10-29 | $15.59K 10-Q · filed 2018-10-29 | ||||||
| 2017-06-30 | $3.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-01 | $8.57K 10-Q · filed 2018-08-01 | |||||||
| 2017-03-31 | $5.16K 10-Q · filed 2018-04-30 | ||||||||
| 2016-12-31 | $2.45M 10-K · filed 2019-02-26 | $2.45M 10-K · filed 2017-03-01 | |||||||
| 2014-12-31 | $1.75M 10-K · filed 2016-02-29 | ||||||||
| 2012-12-31 | $161.29K 10-K · filed 2014-03-06 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-08-07 | $4.73M 10-K/A · filed 2013-08-07 | |||||||
| 2011-09-30 | $4.73M 10-Q · filed 2012-11-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOLIFE SOLUTIONS INC (BLFS) | United States | $1.887B | 23.80 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| LivaNova PLC (LIVN) | $4.158B | 24.01 | |
| Integer Holdings Corp (ITGR) | United States | $4.289B | 25.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |